[HTML][HTML] Epidemiology of stomach cancer
Despite a decline in incidence and mortality during the last decades, stomach cancer is one
of the main health challenges worldwide. According to the GLOBOCAN 2020 estimates …
of the main health challenges worldwide. According to the GLOBOCAN 2020 estimates …
Current state and next-generation CAR-T cells in multiple myeloma
S Manier, T Ingegnere, G Escure, C Prodhomme… - Blood Reviews, 2022 - Elsevier
Chimeric antigen receptor T cells (CAR-T cells) have emerged as a potentially
transformative new approach to treating hematological malignancies. Ide-cel, an autologous …
transformative new approach to treating hematological malignancies. Ide-cel, an autologous …
Counts, incidence rates, and trends of pediatric cancer in the United States, 2003-2019
Background Cancer is a leading cause of death by disease among children and
adolescents in the United States. This study updates cancer incidence rates and trends …
adolescents in the United States. This study updates cancer incidence rates and trends …
Androgen receptor signaling in prostate cancer and therapeutic strategies
Simple Summary Early-stage and castration-sensitive prostate cancer (PCa) growth is solely
mediated by androgen signaling pathways. AR signaling inhibitors (ARSIs) have …
mediated by androgen signaling pathways. AR signaling inhibitors (ARSIs) have …
Diagnostic and prognostic potential of the microbiome in ovarian cancer treatment response
AE Asangba, J Chen, KM Goergen, MC Larson… - Scientific reports, 2023 - nature.com
Ovarian cancer (OC) is the second most common gynecological malignancy and the fifth
leading cause of death due to cancer in women in the United States mainly due to the late …
leading cause of death due to cancer in women in the United States mainly due to the late …
Baricitinib safety for events of special interest in populations at risk: analysis from randomised trial data across rheumatologic and dermatologic indications
PC Taylor, T Bieber, R Alten, T Witte, J Galloway… - Advances in …, 2023 - Springer
Abstract Introduction Baricitinib, a Janus kinase (JAK) 1/2 inhibitor, is an approved treatment
for rheumatoid arthritis (RA), atopic dermatitis (AD), and alopecia areata (AA). Further …
for rheumatoid arthritis (RA), atopic dermatitis (AD), and alopecia areata (AA). Further …
Validation of a multi-ancestry polygenic risk score and age-specific risks of prostate cancer: A meta-analysis within diverse populations
Background: We recently developed a multi-ancestry polygenic risk score (PRS) that
effectively stratifies prostate cancer risk across populations. In this study, we validated the …
effectively stratifies prostate cancer risk across populations. In this study, we validated the …
Undetectable measurable residual disease is associated with improved outcomes in AML irrespective of treatment intensity
A Bazinet, T Kadia, NJ Short, G Borthakur… - Blood …, 2023 - ashpublications.org
Acute myeloid leukemia (AML) can be treated with either high-or low-intensity regimens.
Highly sensitive assays for measurable residual disease (MRD) now allow for a more …
Highly sensitive assays for measurable residual disease (MRD) now allow for a more …
Five-year cancer survival by stage at diagnosis in Canada
LF Ellison, N Saint-Jacques - Health reports, 2023 - search.proquest.com
Background Cancer survival estimates provide insights into the effectiveness of early
detection and treatment. The stage of cancer at diagnosis is an important determinant of …
detection and treatment. The stage of cancer at diagnosis is an important determinant of …
[HTML][HTML] Clinical and molecular characterization of long-term survivors with extensive-stage small cell lung cancer treated with first-line atezolizumab plus carboplatin …
Abstract Objectives In the Phase I/III IMpower133 study, first-line atezolizumab plus
carboplatin and etoposide (CP/ET) treatment for extensive-stage small cell lung cancer (ES …
carboplatin and etoposide (CP/ET) treatment for extensive-stage small cell lung cancer (ES …